Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec;3(2):187-207.
doi: 10.1007/s40744-016-0040-4. Epub 2016 Aug 12.

Juvenile Idiopathic Arthritis: Diagnosis and Treatment

Gabriella Giancane  1   2 , Alessandro Consolaro  1   2 , Stefano Lanni  1 , Sergio Davì  1 , Benedetta Schiappapietra  1   2 , Angelo Ravelli  3   4
Affiliations
Review

Juvenile Idiopathic Arthritis: Diagnosis and Treatment

Gabriella Giancane et al. Rheumatol Ther. 2016 Dec.

Abstract

Juvenile idiopathic arthritis is a broad term that describes a clinically heterogeneous group of arthritides of unknown cause, which begin before 16 years of age. This term encompasses several disease categories, each of which has distinct presentation, clinical manifestations, and, presumably, genetic background and etiopathogenesis. Although none of the available drugs has curative potential, prognosis has greatly improved as a result of substantial progresses in disease management. The most important new development has been the introduction of the biologic medications, which constitute a valuable treatment option for patients who are resistant to conventional antirheumatic agents. Further insights into the disease pathogenesis and treatment will be provided by the continuous advances in understanding of the mechanisms related to the immune response and inflammatory process, and by the development of new drugs that are capable of selectively inhibiting single molecules or pathways.

Keywords: Biologics; Biomarkers; Drug safety; Imaging; Juvenile idiopathic arthritis; Outcome measures.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Salmon-macular rash in systemic juvenile idiopathic arthritis
Fig. 2
Fig. 2
Arthritis of the right knee in a child with oligoarticular juvenile idiopathic arthritis
Fig. 3
Fig. 3
T1-weighted magnetic resonance imaging of left sacroiliitis in a patient with enthesitis-related arthritis
See this image and copyright information in PMC

References

    1. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369:767–778. doi: 10.1016/S0140-6736(07)60363-8. - DOI - PubMed
    1. Petty RE, Cassidy JT. Textbook of pediatric rheumatology. Philadelphia: Saunders Elsevier; 2011.
    1. Szer I, Kimura Y, Malleson P, Southwood T. Arthritis in children and adolescents. Oxford: Oxford University Press; 2006.
    1. Fujikawa S, Okuni M. Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan. Acta Paediatr Jpn. 1997;39:245–249. doi: 10.1111/j.1442-200X.1997.tb03593.x. - DOI - PubMed
    1. Consolaro A, Ruperto N, Filocamo G, et al. Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: introduction of the EPOCA study. Pediatr Rheumatol Online J. 2012;10:39. doi: 10.1186/1546-0096-10-39. - DOI - PMC - PubMed